Are Hospitals Following Guidelines for VTE Prevention? the Veneous Thromoembolism Study to Assess the Rate of Thromboprophylaxis
Alpesh Amin MD, MBA, FACP
Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study
Marcos De Lima, MD
A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma. A California Consortium Study
Mark Kirschbaum, MD
Recombinant Antidote for Reversal of Anticoagulation by Factor Xa Inhibitors
Uma Sinha, PhD